BioRestorative Therapies, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioRestorative Therapies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • BioRestorative Therapies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $78.1K, a 57.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $78.1K -$106K -57.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $115K -$97.4K -45.8% Mar 31, 2024 10-Q 2024-06-11
Q4 2023 $151K -$90.3K -37.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $155K -$116K -42.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $184K -$116K -38.7% Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $213K -$116K -35.3% Mar 31, 2023 10-Q 2024-06-11
Q4 2022 $242K -$116K -32.4% Dec 31, 2022 10-K/A 2024-06-11
Q3 2022 $271K -$116K -30% Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $300K -$116K -27.9% Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $329K -$116K -26.1% Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $358K -$116K -24.5% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $387K -$116K -23.1% Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $416K -$116K -21.8% Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $445K -$116K -20.7% Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $474K -$116K -19.7% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $503K Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $532K Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $561K Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $590K Dec 31, 2019 10-K 2021-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.